70% of the billion or so tobacco related deaths expected by 2025 will occur in developing countries. Such staggering figures could have a profound eff ect on the global economy. India is the second largest producer and consumer of tobacco products worldwide, but it has taken great strides to be recognised as a global player in the fight against the tobacco epidemic. (Correspondence)

On July 1, England joins the growing list of countries that have introduced laws to protect the public and employees from the harmful eff ects of passive smoking. From July 1, smoking in almost all enclosed public or work places will be illegal, with fines for smokers who break the law and for those who fail to prevent smoking on their premises. (Editorial)

In a firm step towards checking tobacco use, on May 29 the who issued its strongest policy recommendations. It urged all countries to ban smoking at indoor workplaces and public buildings. It asked

Yemen's health ministry recently announced a new strategy to fight malaria in the country at a reduced cost. In place of annual campaigns against the disease, it plans to have permanent teams

power failure

Brazil recently issued a compulsory licence that will allow the manufacture of generic versions of a drug, which is used to treat hiv/aids patients. The drug, Sustiva (efavirenz), is marketed as

AT the time of independence, India faced the twin problems of acute and chronic undernutrition of its children. This was essentially a result of low dietary intake because of poverty and low purchasing power, high prevalence of infection because of poor access to safe drinking water, sanitation and health care and poor utilization of available facilities due to low literacy and lack of awareness.

Angering global drug giants, Thailand's interim regime decided to issue more compulsory licences for import and production of generic HIV/AIDS drugs on February 12, 2007. The rising cost of AIDS

An ongoing case in Madras High Court has brought forth a damning revelation: the Indian government remains confused about its patent laws and the latter are now under threat. A May 2006 petition

Released on July 4, 2006, the national pharmaceutical policy, envisaged as an umbrella policy, was to fix problems related to access to affordable drugs. The policy suggests access would be improved

Pages